Carotenoids from Marine Microalgae as Antimelanoma Agents.

Humans Vemurafenib / pharmacology Microalgae / metabolism Proto-Oncogene Proteins B-raf / genetics Carotenoids / pharmacology Zeaxanthins / pharmacology NF-kappa B Melanoma / pathology Dacarbazine / pharmacology Cell Proliferation Mutation Antineoplastic Agents / pharmacology Cell Line, Tumor
marine carotenoids marine pigments melanoma pigments skin cancer

Journal

Marine drugs
ISSN: 1660-3397
Titre abrégé: Mar Drugs
Pays: Switzerland
ID NLM: 101213729

Informations de publication

Date de publication:
29 Sep 2022
Historique:
received: 06 09 2022
revised: 23 09 2022
accepted: 27 09 2022
entrez: 26 10 2022
pubmed: 27 10 2022
medline: 29 10 2022
Statut: epublish

Résumé

Melanoma cells are highly invasive and metastatic tumor cells and commonly express molecular alterations that contribute to multidrug resistance (e.g., BRAF

Identifiants

DOI: 10.3390/md20100618 PMID: 36286442 PMC: PMC9604797
pubmed: 36286442
pii: md20100618
doi: 10.3390/md20100618
pmc: PMC9604797
pii:
doi:

Substances chimiques

Vemurafenib 207SMY3FQT
Proto-Oncogene Proteins B-raf EC 2.7.11.1
Carotenoids 36-88-4
Zeaxanthins 0
NF-kappa B 0
Dacarbazine 7GR28W0FJI
Antineoplastic Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Contemp Oncol (Pozn). 2018 Mar;22(1A):68-72
pubmed: 29628797
Lancet Oncol. 2015 Apr;16(4):375-84
pubmed: 25795410
J Am Acad Dermatol. 2016 Mar;74(3):395-407; quiz 408-10
pubmed: 26892650
N Engl J Med. 2004 Sep 2;351(10):998-1012
pubmed: 15342808
Cell Mol Life Sci. 2012 May;69(9):1475-91
pubmed: 22076652
Foods. 2020 Aug 13;9(8):
pubmed: 32823574
Mar Drugs. 2018 May 15;16(5):
pubmed: 29762545
J Toxicol Sci. 2009 Oct;34(5):501-10
pubmed: 19797858
Ther Adv Med Oncol. 2019 May 22;11:1758835919851663
pubmed: 31205512
N Engl J Med. 2012 Jul 12;367(2):107-14
pubmed: 22663011
Int Immunol. 2005 Feb;17(2):133-44
pubmed: 15611321
Foods. 2021 Sep 28;10(10):
pubmed: 34681351
Front Oncol. 2018 Mar 07;8:54
pubmed: 29564225
Semin Cancer Biol. 2012 Aug;22(4):319-26
pubmed: 22349515
Hematol Oncol Clin North Am. 2014 Jun;28(3):523-36
pubmed: 24880945
J Exp Clin Cancer Res. 2000 Mar;19(1):21-34
pubmed: 10840932
J Toxicol Environ Health A. 2017;80(13-15):776-787
pubmed: 28850007
Carcinogenesis. 1998 Feb;19(2):373-6
pubmed: 9498292
Front Med (Lausanne). 2018 Aug 30;5:235
pubmed: 30214901
J Agric Food Chem. 2013 Apr 24;61(16):3842-51
pubmed: 23473626
ScientificWorldJournal. 2014 Jan 02;2014:768323
pubmed: 24526922
Lancet. 2014 Sep 20;384(9948):1109-17
pubmed: 25034862
J Cancer Res Clin Oncol. 2019 Feb;145(2):293-301
pubmed: 30627824
Biochim Biophys Acta Rev Cancer. 2019 Apr;1871(2):313-322
pubmed: 30776401
J Sci Food Agric. 2021 Mar 15;101(4):1609-1617
pubmed: 32875593
J Clin Oncol. 2011 Aug 1;29(22):3085-96
pubmed: 21383288
J Exp Med. 2000 Oct 2;192(7):1027-34
pubmed: 11015443
PLoS One. 2017 Feb 23;12(2):e0171872
pubmed: 28231253
Evid Based Complement Alternat Med. 2013;2013:205082
pubmed: 24223611
Lancet. 2018 Sep 15;392(10151):971-984
pubmed: 30238891
Cancers (Basel). 2019 Sep 11;11(9):
pubmed: 31514399
Mol Oncol. 2008 Apr;1(4):395-405
pubmed: 19383313
Nature. 2011 Nov 23;480(7377):387-90
pubmed: 22113612
Environ Toxicol Pharmacol. 2013 Jan;35(1):39-46
pubmed: 23228706
Mar Drugs. 2013 Jan 08;11(1):50-66
pubmed: 23299493
Arch Biochem Biophys. 2011 Aug 1;512(1):96-106
pubmed: 21620794
Mol Cancer Ther. 2013 Dec;12(12):2760-71
pubmed: 24130051
N Engl J Med. 2011 Jun 30;364(26):2507-16
pubmed: 21639808
Nutr Res. 2007 Jun;27(6):336-342
pubmed: 32726891
J Ophthalmol. 2015;2015:392305
pubmed: 26682063
Mar Drugs. 2013 Dec 16;11(12):5130-47
pubmed: 24351910
Clinics (Sao Paulo). 2018 Aug 20;73(suppl 1):e482s
pubmed: 30133563
N Engl J Med. 2015 Jan 1;372(1):30-9
pubmed: 25399551
Mar Drugs. 2013 Nov 01;11(11):4390-406
pubmed: 24189278
Clin Cancer Res. 2009 Sep 15;15(18):5852-60
pubmed: 19737958
Oncology (Williston Park). 2004 Oct;18(11):1443-50; discussion 1457-9
pubmed: 15609471
Ann Transl Med. 2015 Sep;3(15):210
pubmed: 26488006
Immunotargets Ther. 2018 Jun 07;7:35-49
pubmed: 29922629
Biochem Biophys Res Commun. 2013 Oct 4;439(4):580-5
pubmed: 24036125
Cancer Metastasis Rev. 2013 Dec;32(3-4):567-84
pubmed: 23584575
Cancer Discov. 2014 Jan;4(1):94-109
pubmed: 24265153
J Clin Oncol. 2000 Jan;18(1):158-66
pubmed: 10623706
J Biomed Res. 2013 Jul;27(4):254-71
pubmed: 23885265
Pharmgenomics Pers Med. 2013 Jun 07;6:49-56
pubmed: 23843700
Lancet Oncol. 2017 Apr;18(4):435-445
pubmed: 28284557
Cancer Discov. 2014 Jan;4(1):80-93
pubmed: 24265155
Oxid Med Cell Longev. 2020 Aug 26;2020:2647670
pubmed: 32908627
Mar Drugs. 2022 Apr 22;20(5):
pubmed: 35621930
Biochim Biophys Acta. 2016 Apr;1863(4):770-84
pubmed: 26844774
Immunotherapy. 2011 May;3(5):673-90
pubmed: 21554095
Mar Drugs. 2011;9(6):1101-1118
pubmed: 21747749
Contemp Oncol (Pozn). 2018 Mar;22(1A):61-67
pubmed: 29628796
Clin Cancer Res. 2013 Sep 1;19(17):4868-78
pubmed: 23833299
ACS Omega. 2019 Jun 18;4(6):10502-10509
pubmed: 31460147
Mar Drugs. 2019 May 24;17(5):
pubmed: 31137657
N Engl J Med. 2011 Jun 30;364(26):2517-26
pubmed: 21639810
Biomed Res Int. 2015;2015:851387
pubmed: 26171394
N Engl J Med. 2005 Nov 17;353(20):2135-47
pubmed: 16291983
Cell Rep. 2017 May 9;19(6):1189-1201
pubmed: 28494868
Photochem Photobiol. 2008 Mar-Apr;84(2):289-306
pubmed: 18086245
Mar Drugs. 2015 Apr 13;13(4):2196-214
pubmed: 25871295
Cancer Cell. 2010 Dec 14;18(6):683-95
pubmed: 21156289
Ulster Med J. 2014 May;83(2):103-10
pubmed: 25075139
J Nat Med. 2020 Jan;74(1):1-16
pubmed: 31588965
Trends Pharmacol Sci. 2013 Dec;34(12):656-66
pubmed: 24210882
Lancet Oncol. 2013 Mar;14(3):249-56
pubmed: 23414587
Mar Drugs. 2014 Jan 07;12(1):128-52
pubmed: 24402174
Antioxid Redox Signal. 2013 Apr 10;18(11):1307-48
pubmed: 22871022
J Clin Oncol. 2013 May 10;31(14):1767-74
pubmed: 23569304
Nat Rev Drug Discov. 2014 Feb;13(2):140-56
pubmed: 24481312
Oncol Rev. 2017 Mar 24;11(1):326
pubmed: 28382191
J Agric Food Chem. 2016 Dec 14;64(49):9428-9435
pubmed: 27960297
Cancer Discov. 2013 Mar;3(3):350-62
pubmed: 23288408
ESMO Open. 2019 May 23;4(3):e000491
pubmed: 31231568
Mar Drugs. 2018 Jan 24;16(2):
pubmed: 29364147
Lancet. 2012 Jul 28;380(9839):358-65
pubmed: 22735384
Ann Oncol. 2009 Aug;20 Suppl 6:vi1-7
pubmed: 19617292
Food Chem Toxicol. 2010 Aug-Sep;48(8-9):2045-51
pubmed: 20457205
Subcell Biochem. 2016;79:111-39
pubmed: 27485220
Cancer Discov. 2013 Mar;3(3):338-49
pubmed: 23171796
Mar Drugs. 2019 Aug 08;17(8):
pubmed: 31398953
Science. 1996 Mar 22;271(5256):1734-6
pubmed: 8596936

Auteurs

Christiane Adrielly Alves Ferraz (CAA)

UMR 8038 CiTCoM, Faculté de Santé, UFR Pharmacie, Université Paris Cité, 75006 Paris, France.

Raphaël Grougnet (R)

UMR 8038 CiTCoM, Faculté de Santé, UFR Pharmacie, Université Paris Cité, 75006 Paris, France.

Elodie Nicolau (E)

Laboratoire PHYTOX/GENALG, IFREMER, 44311 Nantes, France.

Laurent Picot (L)

UMR CNRS 7266 LIENSs, La Rochelle Université, 17042 La Rochelle, France.
ORCID: 0000-0003-4656-3557

Raimundo Gonçalves de Oliveira Junior (RG)

UMR 8038 CiTCoM, Faculté de Santé, UFR Pharmacie, Université Paris Cité, 75006 Paris, France.
ORCID: 0000-0002-9458-1744

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Carotenoids from Marine Microalgae as...
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › Indoles › Vémurafénib › Carotenoids from Marine Microalgae as...
questionsmedicales.fr › Stades d'organismes › Plancton › Phytoplancton › Microalgues › Carotenoids from Marine Microalgae as...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines tumorales › Protéines oncogènes › Protéines proto-oncogènes › Kinases raf › Protéines proto-oncogènes B-raf › Carotenoids from Marine Microalgae as...
questionsmedicales.fr › Facteurs biologiques › Pigments biologiques › Caroténoïdes › Carotenoids from Marine Microalgae as...
questionsmedicales.fr › Facteurs biologiques › Pigments biologiques › Caroténoïdes › Xanthophylles › Zéaxanthines › Carotenoids from Marine Microalgae as...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Facteurs de transcription › Facteur de transcription NF-kappa B › Carotenoids from Marine Microalgae as...
questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Naevus et mélanomes › Mélanome › Carotenoids from Marine Microalgae as...
questionsmedicales.fr › Composés hétérocycliques › Composés hétéromonocycliques › Azoles › Imidazoles › Dacarbazine › Carotenoids from Marine Microalgae as...
questionsmedicales.fr › Phénomènes physiologiques › Croissance et développement › Croissance › Processus de croissance cellulaire › Prolifération cellulaire › Carotenoids from Marine Microalgae as...
questionsmedicales.fr › Phénomènes génétiques › Variation génétique › Mutation › Carotenoids from Marine Microalgae as...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Antinéoplasiques › Carotenoids from Marine Microalgae as...
questionsmedicales.fr › Cellules › Cellules cultivées › Cellules cancéreuses en culture › Lignée cellulaire tumorale › Carotenoids from Marine Microalgae as...